EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ligand‐Driven Annular‐Epitaxial Growth of CuS‐Au Heterostructures as Trinity Plasmonic Nanozyme for Multimode Diagnosis of Pathogenic Bacteria

Xiaorui Lin, Pengyou Zhou, Miao An, Chenyi Zhu, Yuanfeng Pang iD, Rui Xiao

Advanced Science · 2025

DOI: 10.1002/advs.202500134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiaorui Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Capital Medical University, No.10 Xitoutiao, You An Men, Beijing, 100069, China. Hauptthemen laut MEDLINE: Gold, Metal Nanoparticles, Copper, Biosensing Techniques. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study presents a novel method to control the site‐selective growth of Au nanostars on CuS nanodisc substrate, it indicates that the surfactant ligands play a key role in the architecture control, only CTAC and homologous series with appropriate affinity to CuS can direct the annular‐epitaxial growth of Au nanoparticles on the CuS, which demonstrates superior peroxidase (POD)‐mimic and SERS activity. Mechanistic studies indicate that plasmon‐enhanced catalytic and SERS activity can be attributed to the spatially separated CuS‐Au heterostructure, which supports the light‐triggered hot electron‐hole pairs production and localized surface plasmon resonance hotspots. For practical biosensing, the CuS‐Au heterostructures assembled lateral flow assay (LFA) was used for SERS/catalytic colorimetric/photothermal three‐mode detection of Streptococcus pneumoniae and Klebsiella pneumoniae , with visually colorimetric mode at 103 CFU/mL and quantitative SERS/photothermal modes at 2–10 2 CFU/mL within 15 min, 15 clinical samples were used to validate the assay, the result was 100% concordant to the results of quantitative real‐time PCR. This study provides a unique avenue to controllably produce plasmon‐enhanced nanozyme, which can provide multi‐mode signals for LFA application and meet the requirements of different scenarios.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldMetal NanoparticlesCopperBiosensing TechniquesKlebsiella pneumoniaeStreptococcus pneumoniaeLigandsSurface Plasmon ResonanceHumansSpectrum Analysis, RamanColorimetry

Stichwörter der Autor:innen

CuS‐Au heterostructuresannular‐epitaxial growthligand‐drivenmultimode diagnosis of pathogenic bacteriatrinity plasmonic nanozyme

Substanzen

GoldCopperLigandscupric sulfide

Autor:innen und Institutionen

  • Capital Medical University, No.10 Xitoutiao, You An Men, Beijing, 100069, China.
  • State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 100071, China.

ORCID-Profile: Yuanfeng Pang

Förderung

  • Beijing Natural Science Foundation
  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Lin, X., Zhou, P., An, M., Zhu, C., Pang, Y., & Xiao, R. (2025). Ligand‐Driven Annular‐Epitaxial Growth of CuS‐Au Heterostructures as Trinity Plasmonic Nanozyme for Multimode Diagnosis of Pathogenic Bacteria. Advanced Science. https://doi.org/10.1002/advs.202500134

Vancouver

Lin X, Zhou P, An M, Zhu C, Pang Y, Xiao R. Ligand‐Driven Annular‐Epitaxial Growth of CuS‐Au Heterostructures as Trinity Plasmonic Nanozyme for Multimode Diagnosis of Pathogenic Bacteria. Advanced Science. 2025. doi:10.1002/advs.202500134

BibTeX
@article{Lin2025,
  author = {Lin, Xiaorui and Zhou, Pengyou and An, Miao and Zhu, Chenyi and Pang, Yuanfeng and Xiao, Rui},
  title = {Ligand‐Driven Annular‐Epitaxial Growth of CuS‐Au Heterostructures as Trinity Plasmonic Nanozyme for Multimode Diagnosis of Pathogenic Bacteria},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202500134}
}
Kostenlos starten →